Journal
MOLECULES
Volume 26, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/molecules26092780
Keywords
2-substituted benzo [d] [1; 3] azoles; in vitro cytotoxicity; breast cancer; ERα and GPER; molecular docking
Funding
- CONACYT [62267, A1-S-33933]
- SIP-IPN [2018500, 20190027, 20200028]
- PAPIIT-DGAPA-UNAM [PAPIIT IN210520]
- FORDECYT-PRONACES [FON.INST 22/2020, FOINS 307152]
Ask authors/readers for more resources
Two benzo[d][1,3]azoles 2-substituted with benzyl- and allyl-sulfanyl groups, BTA-1 and BMZ-2, showed promising cytotoxic activities against six human cancer cell lines in vitro. BMZ-2 exhibited comparable inhibitory effects to tamoxifen in some cases and displayed low cytotoxicity against healthy cells. Computational molecular docking studies revealed the affinity and possible interactions of both compounds with the tamoxifen binding site on ER alpha and GPER receptors.
A series of benzo [d] [1,3] azoles 2-substituted with benzyl- and allyl-sulfanyl groups were synthesized, and their cytotoxic activities were in vitro evaluated against a panel of six human cancer cell lines. The results showed that compounds BTA-1 and BMZ-2 have the best inhibitory effects, compound BMZ-2 being comparable in some cases with the reference drug tamoxifen and exhibiting a low cytotoxic effect against healthy cells. In silico molecular coupling studies at the tamoxifen binding site of ER alpha and GPER receptors revealed affinity and the possible mode of interaction of both compounds BTA-1 and BMZ-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available